Stock Markets March 30, 2026

IMAX CEO Begins Temporary Medical Leave as Senior Team Assumes Day-to-Day Duties

Richard Gelfond sidelined by pneumonia; chairman and senior executives to coordinate operations while he recovers

By Ajmal Hussain
IMAX CEO Begins Temporary Medical Leave as Senior Team Assumes Day-to-Day Duties

IMAX said its chief executive, Richard Gelfond, is taking a temporary medical leave while receiving treatment for pneumonia. Daily operations will be run by the cinema operator's senior executive team in coordination with Chairman Darren Throop. Gelfond will miss upcoming events, including industry conferences next week. The company reported fourth-quarter revenue of $125.2 million in February, above analysts' LSEG estimate of $120.7 million.

Key Points

  • CEO on leave - Richard Gelfond is temporarily absent while being treated for pneumonia.
  • Operational continuity - Senior executives will run daily operations in coordination with Chairman Darren Throop.
  • Financial context - IMAX reported $125.2 million in fourth-quarter revenue in February, exceeding the LSEG analysts' estimate of $120.7 million.

IMAX has announced that Chief Executive Officer Richard Gelfond is on a temporary medical leave as he receives treatment for pneumonia. The company said on Monday that its senior executive team will handle the company’s daily operations, working in coordination with Chairman Darren Throop.

In a statement, Throop emphasized the depth of the company’s leadership bench and the team's focus on the company’s trajectory. "We have a strong, deeply experienced senior executive team who are fully engaged, providing regular updates to the board, and remain focused as always on the continued growth and success of IMAX," Throop said.

IMAX also confirmed that Gelfond will not take part in the company’s forthcoming events, explicitly noting his absence from industry conferences scheduled for next week while he is on leave.

The announcement comes after IMAX reported fourth-quarter revenue of $125.2 million in February, a result that exceeded the LSEG-compiled analysts' estimate of $120.7 million.

The company framed the temporary leadership adjustment as an operational continuity measure, designating day-to-day responsibilities to senior executives with oversight from the board via the chairman. The statement did not specify how long the leave will last.

The release provides concrete operational arrangements - delegation of daily management to seasoned executives and coordination by the chairman - and confirms the CEO’s temporary absence from scheduled events. It also reiterates recent financial performance through the fourth-quarter revenue figure published in February.


Summary

IMAX's CEO, Richard Gelfond, will be on temporary medical leave for treatment of pneumonia. Senior executives, in coordination with Chairman Darren Throop, will manage daily operations. Gelfond will miss upcoming industry events next week. The company reported Q4 revenue of $125.2 million, above LSEG's analyst estimate of $120.7 million.


Key points

  • CEO on leave - Richard Gelfond is temporarily absent while being treated for pneumonia.
  • Operational continuity - Senior executives will run daily operations in coordination with Chairman Darren Throop.
  • Financial context - IMAX reported $125.2 million in fourth-quarter revenue in February, exceeding the LSEG analysts' estimate of $120.7 million.
  • Impacted sectors - The development is directly relevant to the cinema and broader entertainment sectors and may be of interest to market participants tracking IMAX.

Risks and uncertainties

  • Unspecified duration of leave - The company described the leave as temporary but did not provide a timeline for Gelfond's return, creating uncertainty about leadership continuity. Sector impacted: corporate governance and investor relations in the markets.
  • Absence from scheduled events - Gelfond will not participate in upcoming events, including industry conferences next week, which introduces uncertainty around planned public engagements and messaging. Sector impacted: cinema industry and industry conference programming.
  • Operational transition - While senior executives are designated to manage daily operations with board oversight, the company did not detail specific role assignments during the CEO's absence, leaving short-term internal execution arrangements less clear. Sector impacted: corporate operations within the entertainment and media space.

Risks

  • Unspecified duration of leave - the company called the leave temporary but did not provide a timeline for the CEO's return; this affects corporate governance and market-facing communications.
  • Absence from scheduled events - Gelfond will not participate in upcoming events, including industry conferences next week; this affects the cinema industry's public engagements.
  • Operational transition details limited - senior executives will manage day-to-day operations with chairman coordination, but specific role assignments during the CEO's absence were not detailed; this impacts corporate operations in the entertainment sector.

More from Stock Markets

Advent to Acquire Minority Stake in Natura as Founders Leave Board Mar 30, 2026 Unilever Nears Agreement to Merge Food Unit with McCormick, Creating $60 Billion Combined Company Mar 30, 2026 Unilever Orders Global Hiring Freeze Citing Middle East Conflict and Energy Pressures Mar 30, 2026 Mexico Stocks Close Higher as Industrials and Consumer Names Lead Gains Mar 30, 2026 Colombian equities slide as COLCAP closes down 0.80% Mar 30, 2026